Ticker

No recent analyst price targets found for POAI.

Latest News for POAI

Predictive Oncology Q4 Earnings Call Highlights

Axe Compute (NASDAQ: AGPU) used its fiscal year 2025 investor presentation to outline its transition toward a GPU compute capacity platform, discuss early commercial traction following its rebrand, and walk investors through financial results that management said were heavily influenced by non-cash accounting impacts tied to digital assets and derivatives. Leadership changes and strategic direction Christopher

Defense World • Apr 3, 2026
Predictive Oncology (NASDAQ:POAI) versus Mitesco (OTCMKTS:MITI) Head-To-Head Comparison

Predictive Oncology (NASDAQ: POAI - Get Free Report) and Mitesco (OTCMKTS:MITI - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends. Analyst Ratings This is a breakdown of current

Defense World • Feb 10, 2026
Financial Analysis: Predictive Oncology (NASDAQ:POAI) and Healthcare Triangle (NASDAQ:HCTI)

Healthcare Triangle (NASDAQ: HCTI - Get Free Report) and Predictive Oncology (NASDAQ: POAI - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends. Analyst Recommendations This is a summary of

Defense World • Jan 30, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for POAI.

No Senate trades found for POAI.

No House trades found for POAI.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top